Feb 24, 2021

European corporates: (active) cash is king

European non-financial corporates have seized the opportunity of state-guaranteed loans to build up excess cash reserves, especially in France, the UK and Italy.
Read more

Feb 23, 2021

QE and the bull market in everything but diversification

By triggering a fresh, global and pronounced round of QE, the Covid-19 crisis has struck another heavy blow to diversification.
Read more
RiskLiteracyCOVER.png

Feb 18, 2021

Risk literacy and choices - Stubbing toes in the dark

We surveyed nearly 7,000 people in seven countries to find out about risk literacy during the Covid-19 crisis.
Read more

Feb 17, 2021

Digital-enabling countries proved more resilient to the Covid-19 economic shock

Our estimates show that an additional point in a country’s 2020 EDI score translated to +0.25pp GDP growth in Q3 2020 y/y.
Read more
Mario Draghi and the Italian economy

Feb 15, 2021

Italy: Draghinomics FAQs

As Italy’s new Prime Minister, Mario Draghi faces a double burden: weak growth momentum and a vaccination delay that could cost EUR10bn.
Read more

Feb 11, 2021

Is the Chinese ox reflating the world, one container at a time?

Amid surging demand for imports from China, a container shortage and a strengthening RMB are pushing up import prices for European firms.
Read more

Feb 09, 2021

China: Riding the silicon ox?

China’s success in product assembly, marketing and design relies on huge chip imports.
Read more

Feb 08, 2021

Big oil: At risk of becoming fossil firms?

After a year of low oil prices and low demand, the hit to profitability will continue in 2021 and 2022.
Read more
Covid-19 vaccines

Feb 04, 2021

Covid-19 vaccines: a USD40bn revenue windfall for pharmaceuticals

Biotech companies and Big Pharma are set to be the winners of the game at the expense of generic manufacturers.
Read more

Result Count1925